Geode Capital Management’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$49.5M Buy
3,323,190
+555,427
+20% +$5.98M ﹤0.01% 1634
2026
Q1
$23.4M Buy
2,767,763
+375,486
+16% +$4.11M ﹤0.01% 1917
2025
Q4
$27M Buy
2,392,277
+332,069
+16% +$4.11M ﹤0.01% 1853
2025
Q3
$30.9M Buy
2,060,208
+29,289
+1% +$426K ﹤0.01% 1774
2025
Q2
$28.7M Buy
2,030,919
+71,939
+4% +$1.28M ﹤0.01% 1769
2025
Q1
$47.1M Buy
1,958,980
+53,614
+3% +$1.89M ﹤0.01% 1407
2024
Q4
$71.2M Buy
1,905,366
+190,754
+11% +$8.9M 0.01% 1206
2024
Q3
$85.7M Buy
1,714,612
+44,174
+3% +$1.72M 0.01% 1085
2024
Q2
$58M Buy
1,670,438
+189,410
+13% +$7.49M 0.01% 1258
2024
Q1
$81M Buy
1,481,028
+54,582
+4% +$2.7M 0.01% 1063
2023
Q4
$61.1M Buy
1,426,446
+263,256
+23% +$8.19M 0.01% 1217
2023
Q3
$30.3M Sell
1,163,190
-35,882
-3% -$746K ﹤0.01% 1550
2023
Q2
$28.7M Buy
1,199,072
+8,578
+0.7% +$148K ﹤0.01% 1622
2023
Q1
$16.3M Buy
1,190,494
+69,890
+6% +$1.11M ﹤0.01% 1936
2022
Q4
$15.6M Buy
+1,120,604
New +$15.8M ﹤0.01% 1943

Other funds holding BHVN

Geode Capital Management's BHVN Position: Q2 2026 in Review

Geode Capital Management increased its Biohaven (BHVN) stake by 20% in Q2 2026, buying an estimated $5.98M and bringing the position to 3,323,190 shares worth $49.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1634.

Geode Capital Management first reported a position in BHVN in Q4 2022 and has held it in 15 quarters since. The position peaked at $85.7M in Q3 2024. 273 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Geode Capital Management held 3,323,190 shares of Biohaven worth $49.5M as of Q2 2026.
  • Geode Capital Management bought 555,427 Biohaven shares in Q2 2026, an estimated $5.98M.
  • Biohaven made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #1634 holding.
  • Geode Capital Management first reported a position in Biohaven in Q4 2022 and has held it in 15 quarters since.
  • Geode Capital Management's Biohaven position peaked at $85.7M in Q3 2024.
  • 273 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.